CYTOTOXIC IMMUNE CELLS MATURATION IN MYELOFIBROSIS: IMPLICATIONS FOR DISEASE PROGRESSION

Autor: Medeiros, M, Garcia, CAB, Binelli, LS, Carvalho, AG, Marani, LO, Scheucher, PS, Schiavinato, JLDS, Palma, LC, Garibaldi, PMM, Figueiredo-Pontes, LL

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2024 46 Supplement 4:S480-S480

IMMUNOPHENOTYPIC SIGNATURE OF LEUKEMIA ARREST STAGE IS ASSOCIATED WITH NPM1/FLT3 MUTATIONAL PROFILE AND PROGNOSIS IN ACUTE MYELOID LEUKEMIA

Autor: Carvalho, AG, Marani, LO, Garcia, CAB, Medeiros, M, Binelli, LS, Costa, AFO, Ferreira, EVB, Schiavinato, JLS, Scheucher, PS, Figueiredo-Pontes, LL

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2024 46 Supplement 4:S364-S365

STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells.

Autor: Vicari HP; Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil., Coelho-Silva JL; Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil., Pereira-Martins DA; Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil., Lucena-Araujo AR; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Lima K; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil., Lipreri da Silva JC; Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil., Scheucher PS; Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil., Koury LC; Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil., de Melo RA; Department of Internal Medicine, University of Pernambuco and Fundação HEMOPE, Recife, Brazil., Bittencourt R; Hematology Division, University Hospital of the Federal University of Rio Grande Do Sul, Porto Alegre, Brazil., Pagnano K; University of Campinas/Hemocentro-Unicamp, Campinas, Brazil., Nunes E; Hematology Division, Federal University of Paraná, Curitiba, Brazil., Fagundes EM; Hematology Division, Federal University of Minas Gerais, Belo Horizonte, Brazil., Kerbauy F; Hematology Division, Federal University of Sao Paulo, Sao Paulo, Brazil., de Figueiredo-Pontes LL; Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil., Costa-Lotufo LV; Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil., Rego EM; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil., Traina F; Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil. ftraina@fmrp.usp.br., Machado-Neto JA; Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil. jamachadoneto@usp.br.

Publikováno v: Investigational new drugs [Invest New Drugs] 2022 Apr; Vol. 40 (2), pp. 438-452. Date of Electronic Publication: 2021 Nov 27.

RECLASSIFICAÇÃO DA LEUCEMIA MIELOIDE AGUDA DE ACORDO COM A CÉLULA DE ORIGEM FENOTIPICAMENTE DEFINIDA

Autor: Macedo, RCB, Garcia, CAB, Madeira, MIA, Costa, AFO, Marani, LO, Scheucher, PS, Schiavinato, J, Pagnano, K, Lino, BK, Kerbaury, F, Nunes, E, Glória, ABF, Rego, EM, Traina, F, Figueired-Pontes, LL

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S248-S249

FREQUÊNCIA E ATIVAÇÃO DE CÉLULAS CITOTÓXICAS ANTITUMORAIS SÃO BIOMARCADORES DE RESPOSTA E REMISSÃO LIVRE DE TRATAMENTO NA LEUCEMIA MIELOIDE CRÔNICA

Autor: Binelli, LS, Palma, LC, Garcia, CAB, Marani, LO, Medeiros, M, Lopes, IA, Scheucher, PS, Schiavinato, JL, Traina, F, Garibaldi, PMM, Castro, FA, Bassan, VL, Duarte, GO, Pagnano, KBB, Figueired-Pontes, LL

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S200-S201